Gregory M Weinhoff - Net Worth and Insider Trading
Gregory M Weinhoff Net Worth
The estimated net worth of Gregory M Weinhoff is at least $2 Million dollars as of 2024-05-24. Gregory M Weinhoff is the CFO of Centessa Pharmaceuticals PLC and owns about 231,099 shares of Centessa Pharmaceuticals PLC (CNTA) stock worth over $2 Million. Details can be seen in Gregory M Weinhoff's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gregory M Weinhoff has not made any transactions after 2022-10-03 and currently still holds the listed stock(s).
Transaction Summary of Gregory M Weinhoff
Gregory M Weinhoff Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gregory M Weinhoff owns 3 companies in total, including Sio Gene Therapies Inc (SIOX) , Amicus Therapeutics Inc (FOLD) , and Centessa Pharmaceuticals PLC (CNTA) .
Click here to see the complete history of Gregory M Weinhoff’s form 4 insider trades.
Insider Ownership Summary of Gregory M Weinhoff
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SIOX | Sio Gene Therapies Inc | 2015-08-12 | Principal Financial Officer |
| FOLD | Amicus Therapeutics Inc | 2007-05-30 | director & 10 percent owner |
| CNTA | Centessa Pharmaceuticals PLC | 2022-10-03 | Chief Financial Officer |
Gregory M Weinhoff Latest Holdings Summary
Gregory M Weinhoff currently owns a total of 1 stock. Gregory M Weinhoff owns 231,099 shares of Centessa Pharmaceuticals PLC (CNTA) as of October 3, 2022, with a value of $2 Million.
Latest Holdings of Gregory M Weinhoff
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals PLC | 2022-10-03 | 231,099 | 8.35 | 1,929,677 |
Holding Weightings of Gregory M Weinhoff
Gregory M Weinhoff Form 4 Trading Tracker
According to the SEC Form 4 filings, Gregory M Weinhoff has made a total of 1 transactions in Centessa Pharmaceuticals PLC (CNTA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Centessa Pharmaceuticals PLC is the sale of 8,901 shares on October 3, 2022, which brought Gregory M Weinhoff around $35,604.
Insider Trading History of Gregory M Weinhoff
- 1
Gregory M Weinhoff Trading Performance
Gregory M Weinhoff Ownership Network
Gregory M Weinhoff Owned Company Details
What does Sio Gene Therapies Inc do?
Who are the key executives at Sio Gene Therapies Inc?
Gregory M Weinhoff is the Principal Financial Officer of Sio Gene Therapies Inc. Other key executives at Sio Gene Therapies Inc include Chief Commercial Officer Parag V Meswani , Chief Executive Officer Pavan Cheruvu , and 10 percent owner Roivant Sciences Ltd. .
Sio Gene Therapies Inc (SIOX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sio Gene Therapies Inc (SIOX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sio Gene Therapies Inc (SIOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sio Gene Therapies Inc (SIOX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sio Gene Therapies Inc Insider Transactions
Gregory M Weinhoff Mailing Address
Above is the net worth, insider trading, and ownership report for Gregory M Weinhoff. You might contact Gregory M Weinhoff via mailing address: C/o Centessa Pharmaceuticals Plc, 3rd Fl., 1 Ashley Rd, Altrincham, Cheshire X0 Wa14 2dt.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
